Therapy News and Research

RSS

White men who exercise at high levels have greater risk for plaque buildup in arteries

White men who exercise at high levels are 86 percent more likely than people who exercise at low levels to experience a buildup of plaque in the heart arteries by middle age, a new study suggests.

16 Oct 2017

Magic mushrooms chemical Psilocybin for treatment of hard-to treat depression

A new study from UK has found efficacy of psilocybin – a chemical found in “magic mushrooms”, in severe depression. The study involved 19 patients with severe depression. The patients took the psilocybin and around half of them improved and reported maintained improvement after 5 weeks of therapy. The patients however also received psychological care along with the treatment.

16 Oct 2017

Factors associated with disparities in breast cancer survival studied

According to a latest study, several factors are responsible for the differences in the survival statistics of the non-elderly women with breast cancer. For example in 2012, the health reports had revealed that black women have a 43% higher risk of death when affected with breast cancer compared to their white counterparts.

16 Oct 2017

Scientists discover new non-genetic cause of resistance to anti-cancer therapies

The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States.

16 Oct 2017

CHLA and Keck Medicine of USC develop new liquid biopsy for tumor of the retina

Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age. If not diagnosed early, retinoblastoma may result in loss of one or both eyes and can be fatal. Unlike most cancers that are diagnosed using a biopsy, retinoblastoma tumors cannot be directly biopsied.

16 Oct 2017

Endogenous infection marker can help guide antibiotic use

The endogenous infection marker procalcitonin can help to guide the use of antibiotics when treating infections. The course of antibiotic therapy is shortened, and its side effects and mortality rate also decrease, as researchers from the University of Basel and other colleagues report in the journal The Lancet Infectious Diseases.

16 Oct 2017

Investigating new cancer therapy candidates with live-cell imaging

There are two main things that we've worked on in the lab as regards to drug studies. One is identifying new combinations of drugs, and working on why a combination of drugs should work better than each alone.

From Sartorius 16 Oct 2017

FDA advisory committee vote 16-0 for first even gene therapy for rare blindness

A panel of advisors to the United States Food and Drug Administration (FDA) has voted unanimously in favor of an experimental gene therapy to treat patients with a rare kind of hereditary blindness.

16 Oct 2017

Researchers develop new ‘visual biofeedback’ system for speech therapy

A team of researchers in the GIPSA-Lab and at INRIA Grenoble Rhône-Alpes has developed a system that can display the movements of our own tongues in real time.

13 Oct 2017

RUDN University scientists synthesize new range of cytotoxic substances

Scientists from RUDN University have synthesized a number of new cytotoxic substances - the ones that can damage cells. In the future the results of the study can be used in cancer therapy.

13 Oct 2017

Higher vitamin D dosing decreases risk of premature infants having low bone density

Results of a University of Nebraska Medical Center study published in the Oct. 10 issue of PLOS ONE, found if the standard supplementation of 400 IUs of vitamin D is increased to 800 IUs daily there are reductions in the number of premature and preterm babies with extremely low bone density.

13 Oct 2017

Magic mushrooms may effectively reset activity of brain circuits involved in depression

Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.

13 Oct 2017

MD Anderson researchers chosen for national effort to expand reach of cancer immunotherapy

A major national effort to expand the reach of cancer immunotherapy to benefit more patients will draw upon the expertise of a team of researchers at The University of Texas MD Anderson Cancer Center.

13 Oct 2017

USC discovery may one day lead to new therapies for liver cancer

A Keck School of Medicine of USC research team has identified how cancer stem cells survive. This finding may one day lead to new therapies for liver cancer, one of the few cancers in the United States with an incidence rate that continues to balloon.

12 Oct 2017

Salk scientists receive $2.5 million funding to conduct pancreatic cancer clinical study

Salk Professor and HHMI Investigator Ronald Evans has been awarded $2.5 million by Stand Up 2 Cancer (SU2C) as part of a multi-institution team to conduct clinical studies to open up a new avenue for immunotherapy in the treatment of pancreatic cancer.

12 Oct 2017

Cold Spring Harbor Laboratory Press releases new book on cancer evolution

Cold Spring Harbor Laboratory Press announced the release of Cancer Evolution, available on its website in hardcover and ebook formats.

12 Oct 2017

MIT researchers develop new technique to screen for genes that protect against diseases

Using a modified version of the CRISPR genome-editing system, MIT researchers have developed a new way to screen for genes that protect against specific diseases.

12 Oct 2017

Research findings could pave way to new therapies for treating seizures and autism

Recent research discoveries in the development of brain disorders could pave the way to new therapies for treating seizures, and even some children with autism, says a leading oncologist and researcher at the University of Alberta.

12 Oct 2017

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

New potential biomarkers and a novel algorithm could help identify patients at increased risk of suffering from severe neurotoxicity after receiving CD19 CAR T-cell therapy. The study extensively characterized common and occasionally fatal side effects of this immunotherapy.

12 Oct 2017

World’s only Atomo HIV Self Test receives CE Marking from European Union Notified Body

Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that its Atomo HIV Self Test has been granted CE Marking by a European Union Notified Body.

12 Oct 2017

Therapy News and Research

White men who exercise at high levels have greater risk for plaque buildup in arteries

Magic mushrooms chemical Psilocybin for treatment of hard-to treat depression

Factors associated with disparities in breast cancer survival studied

Scientists discover new non-genetic cause of resistance to anti-cancer therapies

CHLA and Keck Medicine of USC develop new liquid biopsy for tumor of the retina

Endogenous infection marker can help guide antibiotic use

Investigating new cancer therapy candidates with live-cell imaging

FDA advisory committee vote 16-0 for first even gene therapy for rare blindness

Researchers develop new ‘visual biofeedback’ system for speech therapy

RUDN University scientists synthesize new range of cytotoxic substances

Higher vitamin D dosing decreases risk of premature infants having low bone density

Magic mushrooms may effectively reset activity of brain circuits involved in depression

MD Anderson researchers chosen for national effort to expand reach of cancer immunotherapy

USC discovery may one day lead to new therapies for liver cancer

Salk scientists receive $2.5 million funding to conduct pancreatic cancer clinical study

Cold Spring Harbor Laboratory Press releases new book on cancer evolution

MIT researchers develop new technique to screen for genes that protect against diseases

Research findings could pave way to new therapies for treating seizures and autism

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

World’s only Atomo HIV Self Test receives CE Marking from European Union Notified Body

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News